Lexicon Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Lexicon Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Lexicon Pharmaceuticals Inc Strategy Report
- Understand Lexicon Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Lexicon Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20220265690A1 | Application | USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND MODERATE RENAL IMPAIRMENT | A61K31/7028; A61P3/10 | August 25, 2022 |
| US20220242897A1 | Application | CONTINUOUS PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN | C07B2200/13; C07H1/06; C07H7/04 | August 04, 2022 |
| US20220235085A1 | Application | PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN | C07B2200/13; C07H1/06; C07H13/08 | July 28, 2022 |
| WO2022155303A1 | Application | SOTAGLIFLOZIN FOR TREATING OR PREVENTING CARDIOVASCULAR DISEASES | A61K31/351; A61K45/06; A61P13/12; A61P9/10 | July 21, 2022 |
| CA2941870C | Grant | INHIBITORS OF ADAPTER ASSOCIATED KINASE 1, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE | A61P25/00; A61P25/02; A61P25/04; A61P25/16; A61P25/18; A61P25/28; A61P3/10; A61P43/00; C07D487/04 | July 19, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer